China National Pharmaceutical Group Corporation announced its first-quarter performance, with a net profit attributable to the parent company of approximately 14.2 billion yuan, a year-on-year decrease of 10.7%

According to the news from Zhitong Finance APP, China National Pharmaceutical Group announced its performance for the first quarter of 2024. The total operating income is approximately RMB 147.266 billion, a year-on-year increase of 1.2%; the net profit attributable to the owners of the parent company is about RMB 1.42 billion, a year-on-year decrease of 10.7%; and the basic earnings per share is RMB 0.46